The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study

BACKGROUND: Tumor necrosis factor (TNF) inhibitors use in patients with rheumatoid arthritis (RA) has raised safety concerns about cancer risk, but study results remain controversial. This largest nationwide study to date compared cancer risk in TNF inhibitor users to non-biologic disease-modifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Boyoon, Park, Hyun Jin, Song, Yun-Kyoung, Oh, Yoon-Jeong, Kim, In-Wha, Oh, Jung Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364556/
https://www.ncbi.nlm.nih.gov/pubmed/35945635
http://dx.doi.org/10.1186/s13075-022-02868-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364556/
https://www.ncbi.nlm.nih.gov/pubmed/35945635
http://dx.doi.org/10.1186/s13075-022-02868-w

Ejemplares similares